Mar26 Appendix 4C Cash Flow Report

Quarterly Activities Report and Appendix 4C - March 2026

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 30

Miscellaneous

Quarterly Activities Report - March 2026

Appendix 4C and Quarterly Activities Report - March 2026

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

ING completes share buyback and announces new programme of up to €1.0 billion

argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

ArcelorMittal S.A.: ArcelorMittal reports first quarter 2026 results

Star Health reports a 16% increase in PAT of INR 911 Crores in FY26 vs FY25; Growth and Operating Metrics improve sharply

ING posts 1Q2026 net result of €1,556 million, driven by continued growth in customer balances and fee income

March 2026 Quarterly Report

Landis+Gyr Announces Sale of Rhebo to Everfield

Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory

2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

Appendix 5B - Quarterly Cash Flows - 31 March 2026

Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025